Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics - Menzies-Gow,A.; Flood-Page,P.; Sehmi,R. (J Allergy Clin Immunol, 2003)